Stay updated on Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to include new information about the Advanced Renal Cell Carcinoma study, specifically the trial designation HCRN GU16-260 and its collaborators, while significant details about the treatment protocol and eligibility criteria have been removed.SummaryDifference54%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
Stay in the know with updates to Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page.